HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

seselin

structure in first source

Networked: 11 relevant articles (4 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Coumarins: 826
        seselin: 11
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Coumarins: 826
        seselin: 11

Experts

1.	Bhuvaragavan, Sreeramulu: 1 article (08/2021)
2.	Janarthanan, Sundaram: 1 article (08/2021)
3.	Muthu Kumar, Thirunavukkarasu: 1 article (08/2021)
4.	Nivetha, Ramanathan: 1 article (08/2021)
5.	Ramanathan, Karuppasamy: 1 article (08/2021)
6.	Akbar, Idhayadhulla: 1 article (01/2021)
7.	Alfarhan, Ahmed H: 1 article (01/2021)
8.	Chidambaram, Sathishkumar: 1 article (01/2021)
9.	El-Sheikh, Mohamed A: 1 article (01/2021)
10.	Radhakrishnan, Surendrakumar: 1 article (01/2021)

Related Diseases

1.	Inflammation (Inflammations) 03/01/2023 - "Correction to "Seselin ameliorates inflammation via targeting Jak2 to suppress the proinflammatory phenotype of macrophages"." 01/01/2019 - "Seselin ameliorates inflammation via targeting Jak2 to suppress the proinflammatory phenotype of macrophages."
2.	Thrombosis (Thrombus) 04/01/2013 - "This study was designed to assess the efficacy of seselin derivatives against murine pulmonary thromboembolism, bleeding time, platelet activation and thrombosis. "
3.	Pulmonary Embolism 04/01/2013 - "This study was designed to assess the efficacy of seselin derivatives against murine pulmonary thromboembolism, bleeding time, platelet activation and thrombosis. "
4.	COVID-19 01/01/2022 - "The results suggested that the seselin had inhibitory potential over multiple SARS-COV-2 targets and hold a high potential to work effectively as a novel drug for COVID-19 if evaluated in experimental setups in the foreseeable future. " 01/01/2022 - "In the pandemic situation of COVID-19 caused by the SARS-COV-2 virus, an in silico effort to evaluate the potentiality of the seselin was made to test its efficacy against multiple targets of SARS-COV-2 such as spike protein S2, COVID-19 main protease and free enzyme of the SARS-CoV-2 (2019-nCoV) main protease. " 01/01/2022 - "The ligand seselin showed the best interaction with receptors, spike protein S2, COVID-19 main protease and free enzyme of the SARS-CoV-2 (2019-nCoV) main protease with a binding energy of -6.3 kcal/mol, -6.9 kcal/mol and -6.7 kcal/mol, respectively. " 01/01/2021 - "The recently synthesised compounds were projected conceptual association for COVID-19 protease and also to explore in anticipation if this protein will help target protease inhibitor drugs such as Calanolide A, Cardatolide A, Collinin, Inophyllum A, Mesuol, Isomesuol, Pteryxin, Rutamarin, Seselin and Suksdorin. "
5.	Sepsis (Septicemia) 01/01/2019 - "Here, we have evaluated the anti-inflammatory activity of seselin in models of sepsis and investigated the underlying molecular mechanism(s). " 01/01/2019 - "In vivo, seselin clearly ameliorated sepsis induced by caecal ligation and puncture. " 01/01/2019 - "In vivo therapeutic effects of seselin was evaluated in two models of sepsis, caecal ligation and puncture or injection of LPS, in C57BL/6 mice. "

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	Peptide Hydrolases (Proteases)
3.	Enzymes
4.	Therapeutic Uses
5.	Protease Inhibitors (Protease Inhibitor)
6.	Ligands
7.	Carcinogens
8.	Antiviral Agents (Antivirals)
9.	Acetone
10.	collinin

Related Therapies and Procedures

1.	Punctures
2.	Ligation